Vycor Medical (VYCO) Net Equity Issued and Repurchased (2010 - 2017)

Vycor Medical (VYCO) has reported Net Equity Issued and Repurchased for 6 consecutive years, with $666.0 the latest figure, recorded in Q4 2017.

• On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $666.0 in Q4 2017; TTM through Sep 2018 was $666.0, a 99.92% decrease from a year earlier, with the FY2017 full-year figure at $842873.0, changed N/A from the prior year.
• Net Equity Issued and Repurchased was $666.0 for Q4 2017 at Vycor Medical, down from $842207.0 in the prior quarter.
• Over five years, Net Equity Issued and Repurchased peaked at $4.1 million in Q1 2014 and troughed at $666.0 in Q4 2017.
• A 3-year average of $1.2 million and a median of $842207.0 in 2017 frame the typical range for Net Equity Issued and Repurchased.
• The widest YoY moves for Net Equity Issued and Repurchased: up 43.04% in 2013, down 43.04% in 2013.
• Over 3 years, Net Equity Issued and Repurchased stood at $28481.0 in 2013, then soared by 3164.84% to $929860.0 in 2014, then sank by 99.93% to $666.0 in 2017.
• The last three Net Equity Issued and Repurchased figures came in at $666.0 (Q4 2017), $842207.0 (Q1 2017), and $929860.0 (Q2 2014), per Business Quant data.